Skip to main content

Table 2 Basal characteristics and clinical features of patients with AS and of normal controls.

From: Association of the programmed cell death 1 (PDCD1) gene polymorphism with ankylosing spondylitis in the Korean population

Characteristic

Patients

Controls

Sex, M:F (%)

88:7 (92.6:7.4)

76:54 (58.5:41.5)

Age (mean ± SD)

33.4 ± 9.4

66.3 ± 5.8

Disease subgroup, n

  

   Idiopathic AS

83

 

   IBD

3

 

   Reactive arthritis

2

 

   Psoriatic arthritis

1

 

   JAS

6

 

Clinical features

  

   Age on initial symptom, years (mean ± SD)

23.1 ± 7.6

 

   Disease duration, months (mean ± SD)

25.9 ± 8.5

 

   Delayed diagnosis, months (mean ± SD)

32.1 ± 38.2

 

   HLA B27+ (n = 84) (%)

74 (88.1)

 

Complications, n (%)

  

   Uveitis

8 (8.4)

 

   Peripheral joint involvement

28 (29.4)

 

   Total hip replacement

13 (13.5)

 

   IgA nephropathy

0 (0)

 

   Heart conduction abnormality

0 (0)

 

   Pneumonitis

0 (0)

 

   Cauda equina syndrome

3 (3.1)

 
  1. AS, ankylosing spondylitis; IBD, inflammatory bowel disease; JAS, juvenile ankylosing spondylitis; HLA, human leukocyte antigen.